Heres the part most people dont realizewhen you see the number on the scale go down, it doesnt necessarily mean youve lost fat
Most patients experience gastrointestinal effects in weeks 14, with symptom severity and duration varying widely
A total of 694 patients were studied
Dana Cohen's GLP-1 treatment offers a tailored approach to weight management that addresses the root causes of metabolic challenges while providing sustainable, long-lasting results
For example, individuals with NAFLD exhibit increased intestinal permeability and prevalence of small intestine bacterial overgrowth, and these factors are associated with the severity of hepatic steatosis 19
Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, et al